Atlas Trials

Phase 2b Study in NASH to Assess IVA337

Clinical trial NCT03008070 · COMPLETED

Trial details

NCT number
NCT03008070
Sponsor
Inventiva Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Steatohepatitis (NASH)
Start date
2017-02-07
Primary completion
2020-02-20
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.